EVO
HEALTHCAREEvotec SE
Live · NASDAQ · May 9, Close
What's Moving EVO Today?
No stock-specific AI insight has been generated for EVO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.24
Fundamentals
Trading
EVO News
21 articles- Evotec Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Evotec (XTRA:EVT) Valuation Check As CFO Transition Draws Fresh Attention To The StockYahoo Finance·May 5, 2026
- Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US-Iran Tensions Escalate Near Strait of HormuzYahoo Finance·May 4, 2026
- Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with AlmirallYahoo Finance·May 4, 2026
- Evotec Receives Grants to Advance Tuberculosis TreatmentYahoo Finance·Apr 30, 2026
- Evotec Announces New Nomination to Board of DirectorsYahoo Finance·Apr 29, 2026
- Evotec SE to Announce First Quarter 2026 Results on May 6, 2026Yahoo Finance·Apr 29, 2026
- Evotec Announces Chief Financial Officer TransitionYahoo Finance·Apr 24, 2026
- H.C. Wainwright Initiates Coverage of Evotec (EVO) with a Buy RatingYahoo Finance·Apr 23, 2026
- Is It Time To Reassess Evotec (XTRA:EVT) After The Recent 24.5% Share Price JumpYahoo Finance·Apr 17, 2026
- Evotec (XTRA:EVT) Valuation Check After Recent Share Price ReboundYahoo Finance·Apr 17, 2026
- Evotec Appoints Dr. Ingrid Müller as Chief Operating OfficerYahoo Finance·Apr 15, 2026
- What Makes Evotec (EVO) Appear so AttractiveYahoo Finance·Apr 14, 2026
- Evotec (EVO) Q3 2025 Earnings Call TranscriptMotley Fool·Apr 8, 2026
- Evotec SE (EVOTF) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ChallengesYahoo Finance·Apr 8, 2026
- Evotec Q4 Earnings Call HighlightsMarketbeat·Apr 8, 2026
- Gilead Acquisition Spree Continues With $3 Billion Tubulis DealBenzinga·Apr 7, 2026
- Evotec Nominates Dieter Weinand as Supervisory Board ChairmanYahoo Finance·Apr 7, 2026
- 3 European Dividend Stocks Yielding Up To 8.2%Yahoo Finance·Apr 3, 2026
- Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026Yahoo Finance·Apr 1, 2026
- Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial OfficerYahoo Finance·Apr 1, 2026
All 21 articles loaded
Price Data
52-Week Range
$3.24
Fundamentals
Trading
About Evotec SE
Evotec SE is a prominent global biotechnology firm headquartered in Hamburg, Germany, specializing in end-to-end drug discovery and development solutions for the pharmaceutical and biotech industries. The company employs a synergistic approach, collaborating with both established pharmaceutical giants and cutting-edge academic institutions to accelerate the advancement of a diverse range of therapeutic programs, including small molecules, biologics, and cell therapies. With a strong and growing pipeline of projects, Evotec is strategically positioned to leverage emerging opportunities in the biopharmaceutical landscape, reinforcing its essential role in driving healthcare innovation and improving patient outcomes.